首页> 外文期刊>Heart failure reviews >Percutaneous support of the failing left and right ventriclerecommendations for the use of mechanical device therapy
【24h】

Percutaneous support of the failing left and right ventriclerecommendations for the use of mechanical device therapy

机译:经常支持失败的左侧和右心室供应用于使用机械设备疗法

获取原文
获取原文并翻译 | 示例

摘要

Patients in cardiogenic shock and acute heart failure show high mortality and morbidity despite aggressive and invasive methods such as percutaneous coronary intervention and the use of mechanical support devices. Percutaneous implantation of active hemodynamic support is often the only option for hemodynamic stabilization of patients in cardiogenic shock. Therefore, current guidelines support the use of these devices. Standardized protocols and clinical algorithms for the use of these support devices decrease mortality in these patients. The aim of this review is an overview of current therapies of cardiogenic shock with special focus on mechanical support devices and the suggestion of a clinical algorithm for the differential use of current devices as well as the hemodynamic monitoring of such patients in order to reduce mortality in cardiogenic shock.
机译:患者心形成休克和急性心力衰竭表现出高死亡率和发病率,尽管有侵袭性和侵入性方法,如经皮冠状动脉介入和使用机械支撑装置。 经皮植入活性血液动力学载体通常是患者血流动力学稳定在心形成休克患者的唯一选择。 因此,当前指南支持使用这些设备。 用于使用这些支持装置的标准化协议和临床算法降低了这些患者的死亡率。 本综述的目的是对机械支撑装置特别侧重于机械支撑装置的基因休克疗法的概述以及用于当前设备的差异使用的临床算法以及这些患者的血流动力学监测,以减少死亡率 心形成休克。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号